Overview
- Four Democratic senators have cosponsored the measure, and it now awaits further action in the Senate
- Drug companies poured more than $5 billion into television ads in 2024, accounting for over 30 percent of evening news commercial time
- Senators highlighted that Novo Nordisk spent $263 million advertising Wegovy and charges nearly $1,000 a month for Ozempic in the U.S., compared with under $155 in countries that ban such ads
- Researchers warn that over half of prescription drug ads contain misleading or false claims that may inflate patient demand
- Proponents project a federal ban could raise up to $1.7 billion in annual tax revenue while curbing aggressive marketing tactics